Press release
Deadline on July 5th coming up in Lawsuit for Investors in Altimmune, Inc. (NASDAQ: ALT)
A Deadline is coming up on July 5, 2024 in the lawsuit for certain investors in Altimmune, Inc. (NASDAQ: ALT).
Investors who purchased shares of Altimmune, Inc. (NASDAQ: ALT) have certain options and there are strict and short deadlines running. Deadline: July 5, 2024. NASDAQ: ALT stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the District of Maryland the plaintiff alleges on behalf of purchasers of Altimmune, Inc. (NASDAQ: ALT) common shares between December 1, 2023 and April 26, 2024, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between December 1, 2023 and April 26, 2024, the Defendants made false and/or misleading statements and/or failed to disclose that Altimmune overstated the potential for pemvidutide to stand out from competing GLP-1 agonists based on the drug's efficacy and tolerability results observed in the MOMENTUM Trial, that accordingly, the MOMENTUM Trial results were less significant to pemvidutide's clinical, commercial, and competitive prospects than Defendants had led investors to believe, that as a result of all the foregoing, Defendants had overstated Altimmune's prospects for finding a strategic partner to develop pemvidutide, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Altimmune, Inc. (NASDAQ: ALT) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on July 5th coming up in Lawsuit for Investors in Altimmune, Inc. (NASDAQ: ALT) here
News-ID: 3557519 • Views: …
More Releases from Shareholders Foundation, Inc.
Investigation announced for Investors who hold shares of MicroStrategy Incorpora …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of MicroStrategy Incorporated.
Investors who are current long term investors in MicroStrategy Incorporated (NASDAQ: STRK) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: STRK stocks follows a lawsuit filed against MicroStrategy Incorporated over…
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) Long Term Investor Alert: Investiga …
An investigation on behalf of current long-term investors in shares of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) concerning potential breaches of fiduciary duties by certain directors and officers of Iovance Biotherapeutics, Inc. was announced.
Investors who are current long term investors in Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for…
Lawsuit filed for Investors who lost money with shares of Altimmune, Inc. (NASDA …
An investor, who purchased shares of Altimmune, Inc. (NASDAQ: ALT), filed a lawsuit over alleged violations of Federal Securities Laws by Altimmune, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Altimmune, Inc. (NASDAQ: ALT) have certain options and for certain investors are short and strict deadlines running. Deadline: October 6, 2025. NASDAQ: ALT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Investigation announced for Long-Term Investors in shares of Elevance Health, In …
An investigation was announced for current long-term investors in shares of Elevance Health, Inc. (NYSE: ELV) concerning potential breaches of fiduciary duties by certain directors of Elevance Health, Inc.
Investors who are current long term investors in Elevance Health, Inc. (NYSE: ELV) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors…
More Releases for Altimmune
Nasal Vaccines Market Top Companies Study - Vaxart, Inc, FluGen Inc, Altimmune, …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Nasal Vaccines Market - Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Subunit, Recombinant, and Conjugate Vaccines), By Application (Influenza, COVID-19), Trends, Industry Competition Analysis, Revenue And Forecast To 2034."
The Global Nasal Vaccines Market is estimated to reach over USD 935.2 Mn by 2034, exhibiting a CAGR of 8.6% during the forecast period.
Get Free Access…
Biodefense Market Future Business Opportunities 2025-2032 | XOMA corporation, Al …
Latest Report, titled "Biodefense Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Biodefense market has been expanding significantly in recent…
Lawsuit filed for Investors who lost money with shares of Altimmune, Inc. (NASDA …
An investor, who purchased shares of Altimmune, Inc. (NASDAQ: ALT), filed a lawsuit over alleged violations of Federal Securities Laws by Altimmune, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Altimmune, Inc. (NASDAQ: ALT) have certain options and for certain investors are short and strict deadlines running. Deadline: July 5, 2024. NASDAQ: ALT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Investigation announced for Investors in shares of Altimmune, Inc. (NASDAQ: ALT) …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Altimmune, Inc.
Investors who purchased shares of Altimmune, Inc. (NASDAQ: ALT) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Altimmune, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
Gaithersburg, MD based Altimmune,…
Typhoid Vaccines Market to see Huge Growth by 2025 | Altimmune, Bavarian Nordic …
A new business intelligence report released by HTF MI with title "Global Typhoid Vaccines Market Report 2019 - Market Size, Share, Price, Trend and Forecast" is designed covering micro level of analysis by manufacturers and key business segments. The Global Typhoid Vaccines Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and…
Bioterrorism Market to Witness Huge Growth by 2025: Key Players - Altimmune, Bav …
HTF MI recently introduced Global Bioterrorism Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Altimmune, Bavarian Nordic, DynPort Vaccine Company (DVC), Emergent BioSolutions, Acambis, Achaogen, Cleveland…
